Source: CNW

Press Release: GSK : Public Communication - Health Canada Endorsed Important Safety Information on ARZERRA™ (ofatumumab)

Subject: ARZERRA™ (ofatumumab) - Fatal Infusion Reaction in a patient with Chronic Lymphocytic Leukemia (CLL) MISSISSAUGA, ON, Aug. 6, 2014 /CNW/ - GlaxoSmithKline Inc., in consultation with He...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100